Genomic landscape of angiosarcoma: A targeted and immunotherapy biomarker analysis of 143 patients.
2020
11545Background: Targeted therapies for angiosarcoma (AS) patients have limited efficacy. Although significant responses to immunotherapy (IO-therapy) have been observed in cutaneous AS, its effica...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI